The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients

PURPOSE: This post hoc analysis evaluated treatment effects, safety, and pharmacokinetics of enzalutamide in Korean patients in the phase 3, double-blind, placebo-controlled PREVAIL trial. MATERIALS AND METHODS: Asymptomatic or mildly symptomatic chemotherapy-naive men with metastatic castration-res...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Investig Clin Urol
Glavni autori: Kim, Choung-Soo, Theeuwes, Ad, Kwon, Dong Deuk, Choi, Young Deuk, Chung, Byung Ha, Lee, Hyun Moo, Lee, Kang Hyun, Lee, Sang Eun
Format: Artigo
Jezik:Inglês
Izdano: The Korean Urological Association 2016
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869571/
https://ncbi.nlm.nih.gov/pubmed/27195316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2016.57.3.174
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items